Clinical Trial Update: Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates. [Phase 1, Phase 2]

View source ↗

Summary

This document describes an ongoing Phase 1/2 clinical trial by NIAID evaluating vaginal microbiome seeding in cesarean-delivered newborns and its impact on heal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cesarean Delivery Affecting Newborn, Obesity, Childhood | Phase 1, Phase 2 | Status: RECRUITING